Evogene
Quarterly Financials
| Values in thousands | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
Revenue | $3,853 | $314 | $312 | $884 |
Gross Profit | -241 | -1,970 | 155 | 748 |
EBITDA | -11,295 | -6,459 | -1,994 | -2,610 |
EBIT | -11,497 | -6,722 | -2,275 | -2,900 |
Net Income | -7,827 | -5,309 | 3,874 | -4,462 |
Net Change In Cash | 3,853 | 314 | 312 | 884 |
Free Cash Flow | -2,956 | -3,018 | -3,801 | -2,303 |
Cash | 8,543 | 12,956 | 5,626 | 8,329 |
Basic Shares | 9,738 | 8,718 | 8,716 | 7,225 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $3,853 | $5,577 | $2,982 | $1,675 |
Gross Profit | -241 | 3,197 | 1,492 | 766 |
EBITDA | -12,197 | -13,364 | -20,532 | -27,009 |
EBIT | -13,341 | -14,745 | -21,832 | -29,589 |
Net Income | -8,485 | -16,485 | -23,879 | -26,638 |
Net Change In Cash | 3,853 | 5,577 | 2,982 | 1,675 |
Free Cash Flow | -13,637 | -20,326 | -22,362 | -24,849 |
Cash | 12,956 | 15,301 | 20,772 | 28,980 |
Basic Shares | 7,874 | 5,697 | 4,568 | 4,121 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | -$0.60 |
2025-12-31 | -$0.61 |
2025-09-30 | -$0.31 |
2025-06-30 | -$0.62 |